Review



mab against human cd25  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Miltenyi Biotec mab against human cd25
    Mab Against Human Cd25, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 51 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mab against human cd25/product/Miltenyi Biotec
    Average 95 stars, based on 51 article reviews
    mab against human cd25 - by Bioz Stars, 2026-02
    95/100 stars

    Images



    Similar Products

    95
    Miltenyi Biotec mab against human cd25
    Mab Against Human Cd25, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mab against human cd25/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    mab against human cd25 - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    90
    Thermo Fisher mabs against human cd25
    Immunosuppression of UCX® and UCX®-ATMP. (A) Suppression of T cell activation was assayed by incubating <t>CD3,</t> CD28 and IL2 activated peripheral blood mononucleated cells (PBMCs) from two different donors with irradiated UCX® and UCX®- advanced therapy medicinal product (ATMP) and measuring lymphocyte proliferation (B) Treg conversion was measured in the same cells by culturing irradiated cells with <t>CD3</t> + CD4 + CD25 - T-cells and comparing the percentage of converted CD3 + CD4 + CD25 + Foxp3 + regulatory T-cells with unstimulated cells (negative control) or induced conversion with TGFβ. Results are represented as mean ± SEM.
    Mabs Against Human Cd25, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mabs against human cd25/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    mabs against human cd25 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson pe conjugated mabs against human cd25
    Immunosuppression of UCX® and UCX®-ATMP. (A) Suppression of T cell activation was assayed by incubating <t>CD3,</t> CD28 and IL2 activated peripheral blood mononucleated cells (PBMCs) from two different donors with irradiated UCX® and UCX®- advanced therapy medicinal product (ATMP) and measuring lymphocyte proliferation (B) Treg conversion was measured in the same cells by culturing irradiated cells with <t>CD3</t> + CD4 + CD25 - T-cells and comparing the percentage of converted CD3 + CD4 + CD25 + Foxp3 + regulatory T-cells with unstimulated cells (negative control) or induced conversion with TGFβ. Results are represented as mean ± SEM.
    Pe Conjugated Mabs Against Human Cd25, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe conjugated mabs against human cd25/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    pe conjugated mabs against human cd25 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson pe/cy™7-conjugated mouse mab against human cd25 2a3, igg 1
    Immunosuppression of UCX® and UCX®-ATMP. (A) Suppression of T cell activation was assayed by incubating <t>CD3,</t> CD28 and IL2 activated peripheral blood mononucleated cells (PBMCs) from two different donors with irradiated UCX® and UCX®- advanced therapy medicinal product (ATMP) and measuring lymphocyte proliferation (B) Treg conversion was measured in the same cells by culturing irradiated cells with <t>CD3</t> + CD4 + CD25 - T-cells and comparing the percentage of converted CD3 + CD4 + CD25 + Foxp3 + regulatory T-cells with unstimulated cells (negative control) or induced conversion with TGFβ. Results are represented as mean ± SEM.
    Pe/Cy™7 Conjugated Mouse Mab Against Human Cd25 2a3, Igg 1, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe/cy™7-conjugated mouse mab against human cd25 2a3, igg 1/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    pe/cy™7-conjugated mouse mab against human cd25 2a3, igg 1 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher mabs against human cd25-pe (bc96) antibody
    Immunosuppression of UCX® and UCX®-ATMP. (A) Suppression of T cell activation was assayed by incubating <t>CD3,</t> CD28 and IL2 activated peripheral blood mononucleated cells (PBMCs) from two different donors with irradiated UCX® and UCX®- advanced therapy medicinal product (ATMP) and measuring lymphocyte proliferation (B) Treg conversion was measured in the same cells by culturing irradiated cells with <t>CD3</t> + CD4 + CD25 - T-cells and comparing the percentage of converted CD3 + CD4 + CD25 + Foxp3 + regulatory T-cells with unstimulated cells (negative control) or induced conversion with TGFβ. Results are represented as mean ± SEM.
    Mabs Against Human Cd25 Pe (Bc96) Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mabs against human cd25-pe (bc96) antibody/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    mabs against human cd25-pe (bc96) antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher mabs against human cd3, cd4, and cd25 antibody
    UCX are more potent immunosuppressors than BM-MSCs. (a) Activation of PBMCs from two different donors was induced by incubation with anti-CD3, anti-CD28, and IL-2 (control). Suppression of lymphocyte proliferation was analysed in the presence of irradiated non-MSCs (Molt4), BM-MSCs, and UCX (both naïve and primed with 10 ng/mL of TNF α and IFN γ ). Independent of donor, lymphocyte proliferation was significantly suppressed when cells were cocultured with MSCs, but not with non-MSCs. Values are represented as mean ± s.e.m. and statistically significant differences are indicated by asterisks (nonparametric t -test Mann Whitney, ∗ P < 0.05). (b) Treg conversion was assayed by using FACS-sorted CD3 + CD4 + <t>CD25</t> − T cells that were activated with anti-CD3, anti-CD28, and IL-2 alone and with the addition of TGF- β . The effect of irradiated UCX and BM-MSCs in T cell conversion was analysed in cultures without exogenous TGF- β by flow cytometry analysis of CD25 and Foxp3 expression. Values are represented as mean ± s.e.m. and statistically significant differences are indicated by asterisks (unpaired t -test, ∗ P < 0.05).
    Mabs Against Human Cd3, Cd4, And Cd25 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mabs against human cd3, cd4, and cd25 antibody/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    mabs against human cd3, cd4, and cd25 antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher mabs against human cd3, cd4, cd25 antibody
    UCX are more potent immunosuppressors than BM-MSCs. (a) Activation of PBMCs from two different donors was induced by incubation with anti-CD3, anti-CD28, and IL-2 (control). Suppression of lymphocyte proliferation was analysed in the presence of irradiated non-MSCs (Molt4), BM-MSCs, and UCX (both naïve and primed with 10 ng/mL of TNF α and IFN γ ). Independent of donor, lymphocyte proliferation was significantly suppressed when cells were cocultured with MSCs, but not with non-MSCs. Values are represented as mean ± s.e.m. and statistically significant differences are indicated by asterisks (nonparametric t -test Mann Whitney, ∗ P < 0.05). (b) Treg conversion was assayed by using FACS-sorted CD3 + CD4 + <t>CD25</t> − T cells that were activated with anti-CD3, anti-CD28, and IL-2 alone and with the addition of TGF- β . The effect of irradiated UCX and BM-MSCs in T cell conversion was analysed in cultures without exogenous TGF- β by flow cytometry analysis of CD25 and Foxp3 expression. Values are represented as mean ± s.e.m. and statistically significant differences are indicated by asterisks (unpaired t -test, ∗ P < 0.05).
    Mabs Against Human Cd3, Cd4, Cd25 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mabs against human cd3, cd4, cd25 antibody/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    mabs against human cd3, cd4, cd25 antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher mabs against human cd3, cd4 and cd25 antibody
    Immunosuppression of UCX® and UCX®-ATMP. (A) Suppression of T cell activation was assayed by incubating CD3, CD28 and IL2 activated peripheral blood mononucleated cells (PBMCs) from two different donors with irradiated UCX® and UCX®- advanced therapy medicinal product (ATMP) and measuring lymphocyte proliferation (B) Treg conversion was measured in the same cells by culturing irradiated cells with CD3 + CD4 + <t>CD25</t> - T-cells and comparing the percentage of converted CD3 + CD4 + CD25 + Foxp3 + regulatory T-cells with unstimulated cells (negative control) or induced conversion with TGFβ. Results are represented as mean ± SEM.
    Mabs Against Human Cd3, Cd4 And Cd25 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mabs against human cd3, cd4 and cd25 antibody/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    mabs against human cd3, cd4 and cd25 antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    Immunosuppression of UCX® and UCX®-ATMP. (A) Suppression of T cell activation was assayed by incubating CD3, CD28 and IL2 activated peripheral blood mononucleated cells (PBMCs) from two different donors with irradiated UCX® and UCX®- advanced therapy medicinal product (ATMP) and measuring lymphocyte proliferation (B) Treg conversion was measured in the same cells by culturing irradiated cells with CD3 + CD4 + CD25 - T-cells and comparing the percentage of converted CD3 + CD4 + CD25 + Foxp3 + regulatory T-cells with unstimulated cells (negative control) or induced conversion with TGFβ. Results are represented as mean ± SEM.

    Journal: Stem Cell Research & Therapy

    Article Title: Towards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data

    doi: 10.1186/scrt398

    Figure Lengend Snippet: Immunosuppression of UCX® and UCX®-ATMP. (A) Suppression of T cell activation was assayed by incubating CD3, CD28 and IL2 activated peripheral blood mononucleated cells (PBMCs) from two different donors with irradiated UCX® and UCX®- advanced therapy medicinal product (ATMP) and measuring lymphocyte proliferation (B) Treg conversion was measured in the same cells by culturing irradiated cells with CD3 + CD4 + CD25 - T-cells and comparing the percentage of converted CD3 + CD4 + CD25 + Foxp3 + regulatory T-cells with unstimulated cells (negative control) or induced conversion with TGFβ. Results are represented as mean ± SEM.

    Article Snippet: After five days in culture at 37°C with 5% CO 2 , cells were stained with mAbs against human CD3, CD4 and CD25 (eBioscience) and then stained for huFoxp3 as described by the manufacturer (eBioscience).

    Techniques: Activation Assay, Irradiation, Negative Control

    UCX are more potent immunosuppressors than BM-MSCs. (a) Activation of PBMCs from two different donors was induced by incubation with anti-CD3, anti-CD28, and IL-2 (control). Suppression of lymphocyte proliferation was analysed in the presence of irradiated non-MSCs (Molt4), BM-MSCs, and UCX (both naïve and primed with 10 ng/mL of TNF α and IFN γ ). Independent of donor, lymphocyte proliferation was significantly suppressed when cells were cocultured with MSCs, but not with non-MSCs. Values are represented as mean ± s.e.m. and statistically significant differences are indicated by asterisks (nonparametric t -test Mann Whitney, ∗ P < 0.05). (b) Treg conversion was assayed by using FACS-sorted CD3 + CD4 + CD25 − T cells that were activated with anti-CD3, anti-CD28, and IL-2 alone and with the addition of TGF- β . The effect of irradiated UCX and BM-MSCs in T cell conversion was analysed in cultures without exogenous TGF- β by flow cytometry analysis of CD25 and Foxp3 expression. Values are represented as mean ± s.e.m. and statistically significant differences are indicated by asterisks (unpaired t -test, ∗ P < 0.05).

    Journal: Stem Cells International

    Article Title: What Makes Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells Superior Immunomodulators When Compared to Bone Marrow Derived Mesenchymal Stromal Cells?

    doi: 10.1155/2015/583984

    Figure Lengend Snippet: UCX are more potent immunosuppressors than BM-MSCs. (a) Activation of PBMCs from two different donors was induced by incubation with anti-CD3, anti-CD28, and IL-2 (control). Suppression of lymphocyte proliferation was analysed in the presence of irradiated non-MSCs (Molt4), BM-MSCs, and UCX (both naïve and primed with 10 ng/mL of TNF α and IFN γ ). Independent of donor, lymphocyte proliferation was significantly suppressed when cells were cocultured with MSCs, but not with non-MSCs. Values are represented as mean ± s.e.m. and statistically significant differences are indicated by asterisks (nonparametric t -test Mann Whitney, ∗ P < 0.05). (b) Treg conversion was assayed by using FACS-sorted CD3 + CD4 + CD25 − T cells that were activated with anti-CD3, anti-CD28, and IL-2 alone and with the addition of TGF- β . The effect of irradiated UCX and BM-MSCs in T cell conversion was analysed in cultures without exogenous TGF- β by flow cytometry analysis of CD25 and Foxp3 expression. Values are represented as mean ± s.e.m. and statistically significant differences are indicated by asterisks (unpaired t -test, ∗ P < 0.05).

    Article Snippet: After 5 days in culture at 37°C with 5% CO 2 , cells were stained with mAbs against human CD3, CD4, and CD25 (eBioscience, San Diego, CA, USA) and then stained for huFoxp3 as described by the manufacturer (eBioscience, San Diego, CA, USA).

    Techniques: Activation Assay, Incubation, Control, Irradiation, MANN-WHITNEY, Flow Cytometry, Expressing

    UCX are more potent immunosuppressors than BM-MSCs. (a) Activation of PBMCs from two different donors was induced by incubation with anti-CD3, anti-CD28, and IL-2 (control). Suppression of lymphocyte proliferation was analysed in the presence of irradiated non-MSCs (Molt4), BM-MSCs, and UCX (both naïve and primed with 10 ng/mL of TNF α and IFN γ ). Independent of donor, lymphocyte proliferation was significantly suppressed when cells were cocultured with MSCs, but not with non-MSCs. Values are represented as mean ± s.e.m. and statistically significant differences are indicated by asterisks (nonparametric t -test Mann Whitney, ∗ P < 0.05). (b) Treg conversion was assayed by using FACS-sorted CD3 + CD4 + CD25 − T cells that were activated with anti-CD3, anti-CD28, and IL-2 alone and with the addition of TGF- β . The effect of irradiated UCX and BM-MSCs in T cell conversion was analysed in cultures without exogenous TGF- β by flow cytometry analysis of CD25 and Foxp3 expression. Values are represented as mean ± s.e.m. and statistically significant differences are indicated by asterisks (unpaired t -test, ∗ P < 0.05).

    Journal: Stem Cells International

    Article Title: What Makes Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells Superior Immunomodulators When Compared to Bone Marrow Derived Mesenchymal Stromal Cells?

    doi: 10.1155/2015/583984

    Figure Lengend Snippet: UCX are more potent immunosuppressors than BM-MSCs. (a) Activation of PBMCs from two different donors was induced by incubation with anti-CD3, anti-CD28, and IL-2 (control). Suppression of lymphocyte proliferation was analysed in the presence of irradiated non-MSCs (Molt4), BM-MSCs, and UCX (both naïve and primed with 10 ng/mL of TNF α and IFN γ ). Independent of donor, lymphocyte proliferation was significantly suppressed when cells were cocultured with MSCs, but not with non-MSCs. Values are represented as mean ± s.e.m. and statistically significant differences are indicated by asterisks (nonparametric t -test Mann Whitney, ∗ P < 0.05). (b) Treg conversion was assayed by using FACS-sorted CD3 + CD4 + CD25 − T cells that were activated with anti-CD3, anti-CD28, and IL-2 alone and with the addition of TGF- β . The effect of irradiated UCX and BM-MSCs in T cell conversion was analysed in cultures without exogenous TGF- β by flow cytometry analysis of CD25 and Foxp3 expression. Values are represented as mean ± s.e.m. and statistically significant differences are indicated by asterisks (unpaired t -test, ∗ P < 0.05).

    Article Snippet: For the induction of Tregs, PBMCs were collected from the Ficoll gradient after centrifugation at 720 g for 30′ at RT, washed with PBS containing 2% FCS, and then stained with mAbs against human CD3, CD4, and CD25 (eBioscience, San Diego, CA, USA) for cell sorting.

    Techniques: Activation Assay, Incubation, Control, Irradiation, MANN-WHITNEY, Flow Cytometry, Expressing

    Immunosuppression of UCX® and UCX®-ATMP. (A) Suppression of T cell activation was assayed by incubating CD3, CD28 and IL2 activated peripheral blood mononucleated cells (PBMCs) from two different donors with irradiated UCX® and UCX®- advanced therapy medicinal product (ATMP) and measuring lymphocyte proliferation (B) Treg conversion was measured in the same cells by culturing irradiated cells with CD3 + CD4 + CD25 - T-cells and comparing the percentage of converted CD3 + CD4 + CD25 + Foxp3 + regulatory T-cells with unstimulated cells (negative control) or induced conversion with TGFβ. Results are represented as mean ± SEM.

    Journal: Stem Cell Research & Therapy

    Article Title: Towards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data

    doi: 10.1186/scrt398

    Figure Lengend Snippet: Immunosuppression of UCX® and UCX®-ATMP. (A) Suppression of T cell activation was assayed by incubating CD3, CD28 and IL2 activated peripheral blood mononucleated cells (PBMCs) from two different donors with irradiated UCX® and UCX®- advanced therapy medicinal product (ATMP) and measuring lymphocyte proliferation (B) Treg conversion was measured in the same cells by culturing irradiated cells with CD3 + CD4 + CD25 - T-cells and comparing the percentage of converted CD3 + CD4 + CD25 + Foxp3 + regulatory T-cells with unstimulated cells (negative control) or induced conversion with TGFβ. Results are represented as mean ± SEM.

    Article Snippet: After five days in culture at 37°C with 5% CO 2 , cells were stained with mAbs against human CD3, CD4 and CD25 (eBioscience) and then stained for huFoxp3 as described by the manufacturer (eBioscience).

    Techniques: Activation Assay, Irradiation, Negative Control